Beyond the Pink Ribbon: Debunking Breast Cancer Myths That Won't Go Away

Oct 1, 2026 in Breast Cancer

FDA Approves Targeted Drug Combination, Belzutifan + Lenvatinib, After Immunotherapy For Patients With Most Common Type of Kidney Cancer

Sep 30, 2026

Getting a Second Opinion Gave 'Rocky IV' Star Dolph Lundgren a New Treatment Plan Leading to Remission

Sep 30, 2026

What a Key FDA Vote on a New Cancer Detection Test Could Mean for Patients

Sep 29, 2026

Esophageal Cancer Screening Exists, but It's Not for Everyone: Who Should Get Checked

Sep 29, 2026

The Therapies Experts Call the Biggest Breakthroughs in Decades

Sep 24, 2026

Drug Combination, Inluriyo + Verzenio, Offers Hope for ESR1 Mutated Breast Cancer Patients After Hormone Therapy Stops Working

Sep 23, 2026 in Breast Cancer

Updated Data Show Targeted Drug Ibtrozi Can Keep ROS1-Positive Lung Cancer Under Control For Longer

Sep 21, 2026 in Lung Cancer

ctDNA Surveillance Improves Early Detection of Colon Cancer Recurrence, and Experts Say Guidelines Lag Behind

Sep 21, 2026 in Colon Cancer

Prostate Cancer: Leading Oncologists Say Treatment Is Shifting Beyond a One-Size-Fits-All Approach Toward More Personalized Care

Sep 17, 2026

What Men Facing ‘Active Surveillance’ for Prostate Cancer Can Expect and Why

Sep 17, 2026 in Prostate Cancer

New Rybrevant Data Show Where the Drug May Fit Compared With Tagrisso

Sep 17, 2026 in Lung Cancer